Search

UCB SA

Suletud

SektorTervishoid

221 -1.43

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

220

Max

225

Põhinäitajad

By Trading Economics

Sissetulek

28M

1.1B

Müük

16M

4.3B

P/E

Sektori keskmine

19.418

57.366

Aktsiakasum

5.7

Dividenditootlus

0.65

Kasumimarginaal

26.019

Töötajad

9,000

EBITDA

587M

1.4B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+19.23% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.65%

2.16%

Turustatistika

By TradingEconomics

Turukapital

-4.9B

42B

Eelmine avamishind

222.43

Eelmine sulgemishind

221

Uudiste sentiment

By Acuity

9%

91%

6 / 340 Pingereas Healthcare

UCB SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. aug 2026, 23:18 UTC

News
Correlated Moves

The USD/ZAR is lower today, retreating after an early gain and tracking broader market sentiment amid a drop in crude oil prices.

25. aug 2026, 23:16 UTC

News
Correlated Moves

USD/SEK is lower in Tuesday's session, reflecting ongoing weakness near its one-month trading range. The decline aligns with broader trends in correlated pairs.

25. aug 2026, 23:16 UTC

News
Correlated Moves

RTX Corp has secured a $603 million contract for B-52 radar systems. Shares are trading higher in after-market hours following the announcement.

25. aug 2026, 23:16 UTC

News

Insulet Corp shares lower in after-market hours amid a class action lawsuit alleging false statements about manufacturing controls and safety compliance.

25. aug 2026, 23:16 UTC

News

Ultragenyx Pharmaceutical granted nearly 46,000 restricted stock units to new hires, boosting shares in after-market trading amid ongoing strategic initiatives for rare diseases.

25. aug 2026, 23:16 UTC

News

Franklin Resources declared a quarterly dividend of $0.33 per share, contributing to positive sentiment as shares trade higher in after-market hours.

25. aug 2026, 23:12 UTC

News
Correlated Moves

Northrop Grumman received a $216 million contract modification for its Deep Space Advanced Radar Capability program, with shares trading higher in after-market hours.

25. aug 2026, 23:07 UTC

News

United States Oil Fund LP declined after hours amid rising crude inventories and geopolitical tensions in the Strait of Hormuz affecting oil supply dynamics.

25. aug 2026, 23:07 UTC

News

Concerns from Federal Reserve official Barkin about rising U.S. debt may be influencing sentiment. The Vanguard Mortgage-Backed Securities ETF traded roughly flat in after-market hours.

25. aug 2026, 23:06 UTC

Macro Event
News
Correlated Moves

The USD/HUF exchange rate is lower today, influenced by mixed U.S. economic data and unusual volatility in currency movements.

25. aug 2026, 23:06 UTC

News

Mondelez International will participate in the Barclays Global Consumer Staples Conference on September 9, 2026, as shares trade higher in after-market hours.

25. aug 2026, 23:06 UTC

News
Correlated Moves

Salesforce Inc shares declined during after-market hours, influenced by Intuit Inc's significant drop. The stock remains above its 20-day moving average despite the decline.

25. aug 2026, 23:06 UTC

News

Concerns about rising U.S. debt levels and China's stimulus outlook may be influencing investor sentiment, as BND remains roughly flat in after-market trading.

25. aug 2026, 23:06 UTC

News
Social Media

Wolfe Research upgraded Moderna to Peer Perform, citing positive melanoma trial results and estimating peak sales potential at $9.2 billion. Shares are higher in after-market hours.

25. aug 2026, 23:06 UTC

News

Kura Oncology Inc. reached a new 52-week high after CEO Troy Wilson acquired 100,000 shares for approximately $1.24 million, reflecting strong market sentiment.

25. aug 2026, 23:02 UTC

Event
News

Box Inc shares traded lower in after-market hours following second-quarter results that met expectations but lowered fiscal year 2027 adjusted EPS guidance to $1.54.

25. aug 2026, 23:02 UTC

Social Media
News

Intuit Inc. shares fell in after-hours trading following disappointing guidance, despite fourth-quarter results that exceeded expectations with adjusted EPS of $4.03.

25. aug 2026, 23:02 UTC

News

Walt Disney Co is implementing a voluntary early retirement program for executives amid ongoing restructuring efforts. Shares are lower in after-market trading.

25. aug 2026, 23:02 UTC

News

Kohl's Corp appointed Arianne Parisi as Chief Customer Officer to enhance customer engagement. Shares traded higher in after-market hours following the announcement.

25. aug 2026, 23:02 UTC

Event
News
Social Media

Zoom Communications reported strong Q2 results but issued third-quarter guidance below consensus. Shares declined in after-market trading following the lukewarm outlook.

25. aug 2026, 23:02 UTC

News

Market response to declining crude oil prices keeps USD/HKD trading roughly flat. Focus shifts to upcoming core PCE data and the Jackson Hole symposium.

25. aug 2026, 23:01 UTC

Event
News

nCino Inc's stock fell after its Q2 results showed EPS of $0.05, missing expectations, despite revenues of $161 million and raised full-year guidance.

25. aug 2026, 23:01 UTC

Social Media
Event
News

Semtech Corp reported Q2 net sales of $341.9 million, exceeding estimates. Shares are higher in after-market hours amid positive investor sentiment on growth prospects.

25. aug 2026, 23:01 UTC

News

Qfin Holdings Inc. shares declined in after-market trading following significant earnings misses and cautious guidance, despite earlier gains during the session.

25. aug 2026, 22:36 UTC

News

Par Pacific Holdings agreed to sell its 46% stake in Laramie Energy for $485 million, with shares trading higher in after-market hours.

25. aug 2026, 22:06 UTC

News

Electromed Inc reported record fourth-quarter results, but shares declined in after-market trading amid CEO retirement concerns. Net income rose to $11.3 million.

25. aug 2026, 21:02 UTC

News

Renasant Corp announced a leadership transition, naming Catherine Mealor as CFO starting January 1, 2027. Shares traded higher in after-market hours.

25. aug 2026, 21:02 UTC

News

TD Cowen raised the price target on Global Payments to $90.00 while maintaining a Hold rating. Shares advanced modestly in after-market trading.

25. aug 2026, 21:01 UTC

News

Asbury Automotive Group shares are lower in after-market hours following the termination of Chief Human Resources Officer Jed Milstein, effective August 19, 2026.

25. aug 2026, 20:09 UTC

News

OrthoPediatrics launched its 3P Pediatric Plating Platform Hip System for pediatric orthopedic surgeons. Shares are trading lower, continuing a recent trend of declines.

Võrdlus sarnastega

Hinnamuutus

UCB SA Prognoos

Hinnasiht

By TipRanks

19.23% tõus

12 kuu keskmine prognoos

Keskmine 94.86 EUR  19.23%

Kõrge 125 EUR

Madal 74 EUR

Põhineb 7 Wall Streeti analüütiku instrumendi UCB SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

7 ratings

4

Osta

1

Hoia

2

Müü

Sentiment

By Acuity

6 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest UCB SA

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
help-icon Live chat